Description
Detects somatic mutations in BRCA1 and BRCA2 genes in tumor tissue, used to guide treatment decisions in patients with breast or ovarian cancer, particularly in selecting targeted therapies like PARP inhibitors.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.